Colleen Delaney, MD, Pediatric Hematology & Oncology, Seattle, WA, Seattle Children's Hospital

ColleenSusanneDelaneyMD

Pediatric Hematology & Oncology Seattle, WA

Assistant Professor of Pediatrics, University Wash

Dr. Delaney is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Delaney's full profile

Already have an account?

Education & Training

  • University of Washington
    University of WashingtonFellowship, Pediatric Hematology/Oncology, 1999 - 2002
  • UCSF
    UCSFResidency, Pediatrics, 1996 - 1999
  • Harvard Medical School
    Harvard Medical SchoolClass of 1996

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 2001 - 2022
  • CA State Medical License
    CA State Medical License 1998 - Present
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Disability Related to Chronic Graft-Versus-Host Disease After Alternative Donor Hematopoietic Cell Transplantation  
    Mary E Flowers, Brenda M Sandmaier, Rachel B Salit, Colleen Delaney, Filippo Milano, Stephanie J Lee, Haematologica

Abstracts/Posters

  • Demonstration of the Safety of Post Induction Infusion of Ex-Vivo Expanded Cord Blood Progenitor Cells in Pediatric Patients with Relapsed/Refractory Acute Myelogenous...
    Colleen Delaney, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Cord Blood Transplantation Is an Effective Treatment Option in Patients with Myelodysplastic and Myeloproliferative Syndromes
    Colleen Delaney, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • High Incidence of Herpes Zoster after Cord Blood Hematopoietic Cell Transplant Despite Longer Duration of Antiviral Prophylaxis
    Colleen Delaney, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Press Mentions

  • Nohla Therapeutics Announces Hiring of Dr. Sarah Noonberg as Chief Medical Officer and Appointment of Dr. Colleen Delaney as Chief Scientific Officer
    Nohla Therapeutics Announces Hiring of Dr. Sarah Noonberg as Chief Medical Officer and Appointment of Dr. Colleen Delaney as Chief Scientific OfficerJuly 30th, 2018
  • Fred Hutch Tip Sheet: Breast Cancer, Skin Cells as a Cancer Repair Mechanism, HIV Prevention Study, Air Pollution Risk and More
    Fred Hutch Tip Sheet: Breast Cancer, Skin Cells as a Cancer Repair Mechanism, HIV Prevention Study, Air Pollution Risk and MoreAugust 24th, 2017
  • Kleberg Foundation Grant to Support Clinical Trial for Leukemia Patients
    Kleberg Foundation Grant to Support Clinical Trial for Leukemia PatientsAugust 17th, 2017
  • Join now to see all

Hospital Affiliations